News | Interventional Radiology | August 03, 2017

Moffitt Cancer Center Enhances Patient Care with Toshiba Medical's Infinix-i 4-D

System combines interventional radiology and CT to streamline workflow so clinicians can offer faster and safer exams to more patients

Moffitt Cancer Center Enhances Patient Care with Toshiba Medical's Infinix-i 4-D

August 3, 2017 — Cancer patients at Moffitt Cancer Center in Tampa, Fla., now have access to advanced diagnostic imaging for fast and safe exams with the facility’s Infinix-i 4-D computed tomography (CT) system from Toshiba Medical, a Canon Group company. Moffitt, one of the nation’s leading cancer hospitals, is the first healthcare provider in the state of Florida to use the system’s merging of the Infinix-i angiography system and Aquilion Prime CT system for interventional radiology (IR) and oncology procedures. The system may help clinicians improve visualization and workflow and increase patient safety. A ribbon-cutting ceremony was held on July 25 to mark the occasion.

Moffitt is using the Infinix-i 4D CT for a variety of IR and oncology procedures to more efficiently plan, treat and verify in a single clinical setting. The system’s seamless integration of the interventional lab and CT scanner can transform workflow, eliminating the need to transfer patients between departments, decreasing procedure time and maintaining patient safety.

“Time is critical when treating cancer patients, and we acquired the Infinix-i 4-D CT to help us provide faster and safer care to more patients,” said Grace Cabral, patient care manager of interventional radiology at Moffitt. “With the new system we can capture high-quality images more quickly than before without having to transfer patients between machines, which has allowed us to double our embolization case load and significantly reduce wait times for ablations and biopsies. Additionally, the system’s small footprint allowed us to install the Infinix-i 4D CT quickly, with little downtime for construction, so we could begin utilizing it with patients right away.”

The Infinix-i enables clinicians to provide precision and flexibility during intervention with fingertip-to-fingertip and head-to-toe coverage and enables improved patient access with the Access Halo. As a true CT system, the Aquilion PRIME produces image quality that far exceeds CT-like imaging of the interventional lab, according to Toshiba. The company’s third-generation iterative dose reconstruction software, AIDR (Adaptive Iterative Dose Reduction) 3-D Enhanced, offers simplified CT dose reduction, while the Infinix-i has a suite of dose management features including the Dose Tracking System.

For more information: www.medical.toshiba.com

Related Content

Two examples of CT myocardial perfusion (CTP) imaging assessment software. Canon is on the left and GE Healthcare is on the right. Both of these technologies have been around for a few years, but there have been an increasing amount of clinical data from studies showing the accuracy of the technology compared to nuclear imaging, the current stand of care for myocardial perfusion imaging, and cardiac MRI. #SCCT #perfusionimaging 

Two examples of CT myocardial perfusion (CTP) imaging assessment software. Canon is on the left and GE Healthcare is on the right. Both of these technologies have been around for a few years, but there have been an increasing amount of clinical data from studies showing the accuracy of the technology compared to nuclear imaging, the current stand of care for myocardial perfusion imaging, and cardiac MRI.

News | Computed Tomography (CT) | March 16, 2020
March 16, 2020 — The Society of Cardiovascular Computed Tomography (SCCT) released a new...
SIR President Laura Findeiss, M.D., FSIR

SIR President Laura Findeiss, M.D., FSIR

News | Interventional Radiology | February 09, 2020
February 9, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the...
DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges

DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

News | Interventional Radiology | February 07, 2020
February 7, 2020 — An ahead-of-print...
Harel Gadot

Harel Gadot, Founder, Executive Chairman and President at XACT Robotics says their system’s small footprint and high mobility design will enable care providers to treat a broad range of patient care needs.

News | Interventional Radiology | November 01, 2019
November 1, 2019 — XACT Robotics Ltd. announced that its firs
The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

Technology | Interventional Radiology | October 28, 2019
October 28, 2019 — Office based labs (OBLs) and ambulatory surgery centers (ASCs) require a fresh perspective from im
Exact Imaging Receives FDA 510(k) Clearance for Sterile Transperineal Needle Guide
Technology | Ultrasound Imaging | October 24, 2019
Exact Imaging received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sterile Transperineal Needle...
Canon Medical Launches Alphenix Encore Plus Program
News | Angiography | October 09, 2019
In the complex and fast-paced world of healthcare, customers face the challenge of staying up-to-date with the most...